Description
Sunitinib reduces physical activity (assessed with a pedometer) in a patient with metastatic kidney cancer: a case study
€3.03
Sunitinib reduces physical activity (assessed with a pedometer) in a patient with metastatic kidney cancer: a case study
Notifications
Reviews
There are no reviews yet.